Yamashita Health Care Holdings,Inc.

TSE:9265.T

3040 (JPY) • At close August 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024202320222021202020192018201720162015201420132012
Revenue 64,48661,55558,19555,145.8370,131.07864,658.50961,533.25458,692.78852,517.96351,615.29850,31051,04947,132
Cost of Revenue 55,91953,05750,14747,421.40262,620.49557,853.14255,027.80852,380.44646,936.74745,814.79444,47644,84441,532
Gross Profit 8,5678,4988,0487,724.4287,510.5836,805.3676,505.4466,312.3425,581.2165,800.5045,8346,2055,600
Gross Profit Ratio 0.1330.1380.1380.140.1070.1050.1060.1080.1060.1120.1160.1220.119
Reseach & Development Expenses 0000000000000
General & Administrative Expenses 06,9356,3766,2776,0635,7805,5135,4455,1314,9684,9535,0294,760
Selling & Marketing Expenses 0344329310294285271292263248220191170
SG&A 7,7287,2796,7056,5876,3576,0655,7845,7375,394.5675,215.7565,1735,2204,930
Other Expenses 0252181206.666184.735179.83570.08558.94500000
Operating Expenses 7,7287,5316,8866,793.6666,541.7356,244.8355,983.1245,939.0435,394.5675,215.7565,2115,3875,016
Operating Income 8399681,156930.754968.842560.526522.316373.29186.649584.748539837528
Operating Income Ratio 0.0130.0160.020.0170.0140.0090.0080.0060.0040.0110.0110.0160.011
Total Other Income Expenses Net 104-97-5219582.70881.802-140.311-6.449-78.10541.42889-14120.931
Income Before Tax 9438716351,025.5141,051.55642.328382.005366.841108.544626.176627823587
Income Before Tax Ratio 0.0150.0140.0110.0190.0150.010.0060.0060.0020.0120.0120.0160.012
Income Tax Expense 329293423330.023373.058182.626237.583145.7787.811294.029268270266
Net Income 616580219696678.492459.701144.422220.60819.408332.239359553321
Net Income Ratio 0.010.0090.0040.0130.010.0070.0020.00400.0060.0070.0110.007
EPS 249.47227.8385.79272.67265.77180.0756.5787.047.75131.46140.67216.68125.78
EPS Diluted 249.47227.8385.79272.67265.77180.0756.5787.047.75131.46140.67216.68125.78
EBITDA 1,1731,0868401,247.1341,249.835833.232596.711589.532352712.9966781,004813.779
EBITDA Ratio 0.0180.0180.0140.0230.0180.0130.010.010.0070.0140.0130.020.017